Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-20
DOI
10.1038/s41598-022-10230-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients
- (2021) Yang Li et al. Cellular & Molecular Immunology
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution
- (2021) Shuyuan Zhang et al. Nature Communications
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Todd Bradley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
- (2021) Abdelilah Majdoubi et al. JCI Insight
- Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
- (2021) Elizabeth Fraley et al. BMC Medicine
- Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
- (2021) Elizabeth Fraley et al. Cellular & Molecular Immunology
- Exploration of hosts and transmission traits for SARS-CoV-2 based on the k-mer natural vector
- (2021) Yuyan Zhang et al. INFECTION GENETICS AND EVOLUTION
- Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell–cell fusion
- (2021) Chelsea T. Barrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
- (2021) David R. Martinez et al. SCIENCE
- Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy
- (2021) Ming-Liang Ma et al. Cell Discovery
- Coronavirus Infections—More Than Just the Common Cold
- (2020) Catharine I. Paules et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- (2020) Alba Grifoni et al. Cell Host & Microbe
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients
- (2020) Chek Meng Poh et al. Nature Communications
- COVID-19, SARS and MERS: are they closely related?
- (2020) N. Petrosillo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
- (2020) Meng Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
- (2020) Yang Li et al. Cellular & Molecular Immunology
- Seroprevalence of anti‐SARS‐CoV‐2 antibodies in COVID‐19 patients and healthy volunteers up to six months post disease onset
- (2020) Patrícia Figueiredo‐Campos et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- raxmlGUI 2.0: a graphical interface and toolkit for phylogenetic analyses using RAxML
- (2020) Daniel Edler et al. Methods in Ecology and Evolution
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highly conserved influenza T cell epitopes induce broadly protective immunity
- (2019) Christopher S. Eickhoff et al. VACCINE
- Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
- (2019) Thomas Hagan et al. CELL
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- ETE 3: Reconstruction, Analysis, and Visualization of Phylogenomic Data
- (2016) Jaime Huerta-Cepas et al. MOLECULAR BIOLOGY AND EVOLUTION
- Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
- (2016) Alexandra C. Walls et al. NATURE
- Pre-fusion structure of a human coronavirus spike protein
- (2016) Robert N. Kirchdoerfer et al. NATURE
- Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
- (2016) Shakti Singh et al. PLoS One
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
- (2015) Vineet D Menachery et al. NATURE MEDICINE
- Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies
- (2015) W. B. Williams et al. SCIENCE
- From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
- (2013) Rolf Hilgenfeld et al. ANTIVIRAL RESEARCH
- Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
- (2013) Jan Felix Drexler et al. ANTIVIRAL RESEARCH
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
- (2013) R. J. de Groot et al. JOURNAL OF VIROLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started